Archive for August, 2010

Patient satisfaction is a subjective measure and depends on the patient’s preferences and perceived expectations. In this small survey, the patients demonstrated an overall high level of satisfaction with counselling services provided by both pharmacists and nurses. Patients expressed greater satisfaction with the information about medication side effects that was provided by pharmacists, and there [...]

A total of 100 subjects were recruited, 50 of whom were counselled by pharmacists and 50 by nurses. All participants completed the initial interviews over a period of 1 month. The overall mean scores for the level of satisfaction with counselling were not significantly different between patients counselled by pharmacists and those counselled by nurses [...]

Patient Selection Ambulatory patients with latent TB infection and active extrapulmonary disease with Mycobacterium tuberculosis, as well as those with atypical mycobacterial disease, were surveyed for satisfaction with counselling services. Patients with active pulmonary TB were excluded because air exchange in the pharmacy was inadequate (as defined by the Canadian Standards Association). Each patient was [...]

INTRODUCTION Although overall rates of tuberculosis (TB) in Canada are low, the previous gradual decline in disease rates has reached a plateau. In both the United States and Canada certain groups remain at high risk for TB, most notably foreign-born residents, who represent over 50% of cases. Other groups at high risk include Canadian-born Aboriginal [...]

It has been suggested that the minimal absorption associated with rifaximin may make the agent more conducive for long-term use than other antibiotics, which are more readily absorbed and associated with significant side effects. Grande and colleagues conducted a double-blind crossover trial evaluating the use of rifaximin in patients with liver cirrhosis and minimal HE. [...]

Long-term entecavir (Baraclude, Bristol-Myers Squibb) therapy induces durable virologic suppression and his-tologic benefit, including reversal of fibrosis or cirrhosis, in both HBeAg-positive and -negative chronic hepatitis B. Tong and colleagues evaluated long-term histologic outcomes following entecavir therapy in a nucleoside-naive Asian patient population. The investigators analyzed patients who completed the clinical trials ETV-022 or -027 [...]


top